Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

ConditionsThoracoabdominal Aortic Aneurysm Paravisceral Abdominal Aortic Aneurysm

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorWarren J. Gasper, MD

About this trial

This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

greater than or equal to 6 cm in diameter in men,

greater than or equal to 5.5 cm in diameter in women,

and/or larger than 5 cm in diameter and enlarging at a rate of more than 5 mm/year,

and/or iliac aneurysms larger than 4 cm in diameter.

Disqualifiers

Free rupture of the aneurysm.

Pregnancy.

Known allergy to Nitinol, stainless steel, or polyester.

Unwillingness or inability to comply with the follow up schedule.

Trial design

Design model

Single group

Treatments tested in this trial

Endovascular Branched Stent-Graft
Device
Industry manufactured branched stent-graft for treatment of TAAA/PVAAA.

Treatment groups

250 Participants

are divided into 1 treatment group

Group A: InterventionalExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Successful implantation of TAAA branched stent-graft.

Time frame

1 month

Secondary outcomes

Long term success of TAAA branched stent-graft treatment.

Time frame

5 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Warren J. Gasper, MD

Lead sponsor

University of California, San Francisco

Sponsor institution

Source ClinicalTrials.gov

Apply now